Citation Impact
Citing Papers
Childhood maltreatment predicts adult inflammation in a life-course study
2007
A Neural Circuit for Memory Specificity and Generalization
2013 StandoutScienceNobel
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
2010 StandoutScience
Strategy for Dual-Analyte Luciferin Imaging: In Vivo Bioluminescence Detection of Hydrogen Peroxide and Caspase Activity in a Murine Model of Acute Inflammation
2013 StandoutNobel
Self-Rated Global Measure of the Frequency, Intensity, and Burden of Side Effects
2006
Lithium’s Emerging Role in the Treatment of Refractory Major Depressive Episodes: Augmentation of Antidepressants
2010
Efficacy of venlafaxine in major depression resistant to selective serotonin reuptake inhibitors
2002
The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation
2004
Randomized Trial of Sertraline Versus Venlafaxine XR in Major Depression
2005
A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder
2007
A Meta-Analysis of Cytokines in Major Depression
2009 Standout
Comparative Risk for Harms of Second-Generation Antidepressants
2008
Can discrete event simulation be of use in modelling major depression?
2006
Childhood Maltreatment and Psychopathology: A Case for Ecophenotypic Variants as Clinically and Neurobiologically Distinct Subtypes
2013
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and Continuation Treatment of Major Depressive Disorder
2002
Replication of Scopolamine's Antidepressant Efficacy in Major Depressive Disorder: A Randomized, Placebo-Controlled Clinical Trial
2010
Atypical Depression: Useful Concept, but it's Time to Revise the DSM-IV Criteria
2009
Comparison of efficacy and safety of milnacipran and fluoxetine in Korean patients with major depression
2005
Gender differences in depression: Findings from the STAR*D study
2005
Reconsidering the prognosis of major depressive disorder across diagnostic boundaries: full recovery is the exception rather than the rule
2017
Medication Augmentation after the Failure of SSRIs for Depression
2006 Standout
Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial
2007 Standout
Risk for recurrence in depression
2007
Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double‐blind, randomised 6‐month comparative trial with citalopram
2004
Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
2006 Standout
Duloxetine in the Treatment of Depression
2004
Resting-State Functional Connectivity in Major Depression: Abnormally Increased Contributions from Subgenual Cingulate Cortex and Thalamus
2007 Standout
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: major depression summary
2018
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care
2007
Antidepressant Drug Effects and Depression Severity
2010 Standout
Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder
2015
Dose escalation for insufficient response to standard-dose selective serotonin reuptake inhibitors in major depressive disorder
2006
Influence of Patients’ Requests for Direct-to-Consumer Advertised Antidepressants
2005 Standout
Mirtazapine Orally Disintegrating Tablets Versus Venlafaxine Extended Release
2006
Identifying Depressive Subtypes in a Large Cohort Study
2010
Double-Blind Comparison of Escitalopram and Duloxetine in??the??Acute Treatment of Major??Depressive Disorder
2007
The Epidemiology of Major Depressive Disorder
2003 Standout
Cortisol Circadian Rhythm Alterations in Psychotic Major Depression
2006
A Controlled Study of Repetitive Transcranial Magnetic Stimulation in Medication-Resistant Major Depression
2005
Clinical and Demographic Factors Associated With DSM-IV Melancholic Depression
2006
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression
2006 Standout
Differential physiological effects of a low dose and high doses of venlafaxine in major depression
2006
A comparative study of milnacipran and paroxetine in outpatients with major depression
2004
Neural systems approaches to understanding major depressive disorder: An intrinsic functional organization perspective
2012
Functional Neuroimaging of Major Depressive Disorder: A Meta-Analysis and New Integration of Baseline Activation and Neural Response Data
2012
A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients
2006
Tranylcypromine Versus Venlafaxine Plus Mirtazapine Following Three Failed Antidepressant Medication Trials for Depression: A STAR*D Report
2006
Cognition and Depression: Current Status and Future Directions
2010 Standout
Comparative Efficacy, Acceptability, and Tolerability of Augmentation Agents in Treatment-Resistant Depression
2015
Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D
2004
Dose Escalation of Antidepressants in Unipolar Depression: A Meta-Analysis of Double-Blind, Randomized Controlled Trials
2017
Depression
2018 Standout
Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression
2006 Standout
Augmentation of Antidepressants with Atypical Antipsychotics: A Review of the Current Literature
2008
Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder
2006
Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg/day for major depressive disorder in a placebo-controlled trial
2008
Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression.
2006
Switching Antidepressants After a First Selective Serotonin Reuptake Inhibitor in Major Depressive Disorder
2006
Symptom Severity and Exclusion From Antidepressant Efficacy Trials
2002
Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials
2006
S -Adenosyl Methionine (SAMe) Augmentation of Serotonin Reuptake Inhibitors for Antidepressant Nonresponders With Major Depressive Disorder: A Double-Blind, Randomized Clinical Trial
2010
Antidepressant Efficacy of the Antimuscarinic Drug Scopolamine
2006
Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR∗D) study
2003
Sertraline Versus Paroxetine in Major Depression: Clinical Outcome After Six Months of Continuous Therapy
2000
Switching to bupropion in fluoxetine-resistant major depressive disorder.
2003
Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial
2004
Placebo Response in Studies of Major Depression
2002
Psychosocial and clinical predictors of response to pharmacotherapy for depression
2002
An Evaluation of the Quick Inventory of Depressive Symptomatology and the Hamilton Rating Scale for Depression: A Sequenced Treatment Alternatives to Relieve Depression Trial Report
2005
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
2015
Metyrapone as Additive Treatment in Major Depression
2004
Remission and Residual Symptomatology in Major Depression
1998
A Double-blind Comparison Between Bupropion XL and Venlafaxine XR
2006
Monoamine oxidase inhibitors in resistant major depression
1993
Immune consequences of the spontaneous pro-inflammatory status in depressed elderly patients
2003
Combat Duty in Iraq and Afghanistan, Mental Health Problems, and Barriers to Care
2004 Standout
Residual symptoms after partial remission: an important outcome in depression
1995
Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder
2005
Positron emission tomography imaging in depression: a neural systems perspective
2003
Emotion-regulation strategies across psychopathology: A meta-analytic review
2009 Standout
Cognitive Behavior Therapy for Depression? Choose Horses for Courses
2003
Serotonergic function, two-mode models of self-regulation, and vulnerability to depression: What depression has in common with impulsive aggression.
2008
A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A STAR*D Report
2006
Brooding and reflection: Rumination predicts suicidal ideation at 1-year follow-up in a community sample
2007
Treatment of mood disorders
2002
Predictors of antidepressant treatment outcome in melancholia: psychosocial, clinical and biological indicators
1991
Depression With Atypical Features in the National Comorbidity Survey
2003
Quality assessment of meta-analyses of RCTs of pharmacotherapy in major depressive disorder
2004
The empirical status of cognitive-behavioral therapy: A review of meta-analyses
2005 Standout
Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice
2006 Standout
24-Hour Monitoring of Cortisol and Corticotropin Secretion in Psychotic and Nonpsychotic Major Depression
2000
Activity and Connectivity of Brain Mood Regulating Circuit in Depression: A Functional Magnetic Resonance Study
2005
The Effects of Worry and Rumination on Affect States and Cognitive Activity
2006
The prevalence of atypical features across mood, anxiety, and personality disorders
2002
A meta-analysis of the effects of cognitive therapy in depressed patients
1998
Inositol as an add‐on treatment for bipolar depression
2000
Prevalence and clinical features of atypical depression in depressed outpatients: a 467-case study
1999
Individual differences in trait rumination and the neural systems supporting cognitive reappraisal
2005
A Reevaluation of the Exclusion Criteria Used in Antidepressant Efficacy Trials
2002
Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis
2015
New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: Synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity
2008
The pharmacology of putative early-onset antidepressant strategies
2003
Exclusion Criteria Used in Antidepressant Efficacy Trials
2004
Restoring melancholia in the classification of mood disorders
2007
Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus
2005 Standout
Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial
2006
Suicide risk management for the sequenced treatment alternatives to relieve depression study: applied NIMH guidelines
2004
Pharmacologic management of neuropathic pain: Evidence-based recommendations
2007 Standout
Computer-assisted imaging to assess brain structure in healthy and diseased brains
2003
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Diagnosis and definition of treatment-resistant depression
2003
Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response
1999
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
2011 StandoutNature
Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant Action
2006
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
Neurobiology of depression: an integrated view of key findings
2007
Antidepressant Effect on Connectivity of the Mood-Regulating Circuit: An fMRI Study
2005
A review of clinical and experimental observations about antidepressant actions and side effects produced by Hypericum perforatum extracts
2003
Nocturnal catecholamines and immune function in insomniacs, depressed patients, and control subjects
2003
A cognitive model of posttraumatic stress disorder
2000 Standout
Quality of life assessments in major depressive disorder: a review of the literature
2004
A Double-Blind Comparison of Escitalopram and Venlafaxine Extended Release in the Treatment of Major Depressive Disorder
2004
A distributional code for value in dopamine-based reinforcement learning
2020 StandoutNatureNobel
Predictors of Drug Response in Depression
1989
Reducing relapse and recurrence in unipolar depression: A comparative meta-analysis of cognitive-behavioral therapy's effects.
2007
Current Issues in the Classification of Psychotic Major Depression
2007
Clinical Results for Patients With Major Depressive Disorder in theTexas Medication Algorithm Project
2004
A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression
1999
A Comparison of Lithium and T 3 Augmentation Following Two Failed Medication Treatments for Depression: A STAR*D Report
2006
A pathophysiological framework of hippocampal dysfunction in ageing and disease
2011
Unmasking Disease-Specific Cerebral Blood Flow Abnormalities: Mood Challenge in Patients With Remitted Unipolar Depression
2002
Mental Illness and/or Mental Health? Investigating Axioms of the Complete State Model of Health.
2005 Standout
A Randomised Study Comparing Escitalopram with Venlafaxine XR in Primary Care Patients with Major Depressive Disorder
2004
A pooled analysis of two placebo-controlled trials of desvenlafaxine in major depressive disorder
2008
Maximizing the Adequacy of Medication Treatment in Controlled Trials and Clinical Practice: STAR*D Measurement-Based Care
2007
European Psychiatric Association Guidance on psychotherapy in chronic depression across Europe
2016
A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine
2001
Subgenual prefrontal cortex abnormalities in mood disorders
1997 StandoutNature
Discovering Endophenotypes for Major Depression
2004
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
The Hamilton Depression Rating Scale: Has the Gold Standard Become a Lead Weight?
2004
The HPA axis in major depression: classical theories and new developments
2008 Standout
Are All Antidepressants Really the Same? The Case of Fluoxetine
2006
Strength and vulnerability integration: A model of emotional well-being across adulthood.
2010 Standout
Current research trends in early life stress and depression: Review of human studies on sensitive periods, gene–environment interactions, and epigenetics
2011
Treatment of Major Depression With Psychotherapy or Psychotherapy-Pharmacotherapy Combinations
1997
Prevention of Relapse Following Cognitive Therapy vs Medications in Moderate to Severe Depression
2005
A Catalytic Asymmetric 6 π Electrocyclization: Enantioselective Synthesis of 2‐Pyrazolines
2009 StandoutNobel
The effects of scopolamine on sleep and mood in depressed patients with a history of alcoholism and a normal comparison group
1991
Is Depression an Adaptation?
2000
Constructive and unconstructive repetitive thought.
2008 Standout
A double-blind comparison of the efficacy and safety of milnacipran and fluoxetine in depressed inpatients
1998
AKT/PKB Signaling: Navigating the Network
2017 Standout
Algorithms and Collaborative-care Systems for Depression: Are They Effective and Why?
2006
Clinical Versus Actuarial Judgment
1989 StandoutScience
Augmentation strategies for treatment-resistant depression
2008
Comorbid psychiatric disorders in depressed outpatients: Demographic and clinical features
2005
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance Treatment of Major Depressive Disorder and Treatment of Chronic Depressive Disorders and Subthreshold Depressions
2002
Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic
2007 Standout
Bias in Clinical Intervention Research
2006
Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis
2020
Different gender response to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of citalopram and reboxetine
2006
The molecular neurobiology of depression
2008 StandoutNature
Trends in the Development of New Antidepressants. Is there a Light at the End of the Tunnel?
2004
Treatment resistant depression: methodological overview and operational criteria
1999
Rumination and attention in major depression
2007
Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states
2002
Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: A meta-analysis
2002
DEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION
1996
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Cognitive Therapy vs Medications in the Treatment of Moderate to Severe Depression
2005
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
The neurobiology of depression and antidepressant action
2012
Self-Directed Thought and Response to Treatment for Depression: A Preliminary Investigation
2002
The role of glutamate in mood disorders: Results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects
2007
A cost-effectiveness analysis of cognitive behavior therapy and fluoxetine (prozac) in the treatment of depression
1997
Cognitive aspects of chronic depression.
2003
Researcher allegiance and meta-analysis: The case of cognitive therapy for depression.
1995
The "What" and "Why" of Goal Pursuits: Human Needs and the Self-Determination of Behavior
2000 Standout
Efficacy and Safety of Second-Generation Antidepressants in the Treatment of Major Depressive Disorder
2005
Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder
2008
Dual–Dual Action? Combining Venlafaxine and Mirtazapine in the Treatment of Depression
2008
Vagus nerve stimulation for the treatment of depression and other neuropsychiatric disorders
2006
Cloning and functional expression of cDNAs encoding human and rat pancreatic polypeptide receptors.
1996 StandoutNobel
Place navigation impaired in rats with hippocampal lesions
1982 StandoutNatureNobel
Use of fMRI to Predict Recovery From Unipolar Depression With Cognitive Behavior Therapy
2006
Practice Parameters for the Assessment and Treatment of Children and Adolescents With Depressive Disorders
1998
Aging and Health: Effects of the Sense of Control
1986 StandoutScience
ChatGPT: five priorities for research
2023 StandoutNature
Measuring quality of life in depression
2002
Altered Brain Activity in Unipolar Depression Revisited
2016
Cognitive vulnerability to depression: The role of thought suppression and attitude certainty
2002
A controlled comparison of sertraline and fluoxetine in acute and continuation treatment of major depression
1995
Antidepressant Response in Patients With Major Depression Exposed to NSAIDs: A Pharmacovigilance Study
2012
A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A STAR*D Report
2006
Evidence review: efficacy and effectiveness of antidepressant treatment in primary care
2002
Depression and the ironic effects of thought suppression: Therapeutic strategies for improving mental control.
1999
Angst and the amygdala
2006
Marked decrease of neuropeptide Y Y2 receptor binding sites in the hippocampus in murine prion disease
1997 StandoutNobel
Depression: A Decision-Theoretic Analysis
2015
Polycyclic Polyprenylated Acylphloroglucinols
2006 Standout
Mood disorders: neurocognitive models
2015
Definition, Assessment, and Staging of Treatment—Resistant Refractory Major Depression: A Review of Current Concepts and Methods
2007
Inositol hexakisphosphate suppresses excitatory neurotransmission via synaptotagmin-1 C2B domain in the hippocampal neuron
2012 StandoutNobel
Depression: A change of mind
2014 Nature
Behavioral activation treatment for depression: Returning to contextual roots.
2001
Dysthymia
1995
The Inventory of Depressive Symptomatology (IDS): Clinician (IDS‐C) and Self‐Report (IDS‐SR) ratings of depressive symptoms
2000
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines
2000
Rethinking Rumination
2008 Standout
When emotion goes wrong: Realizing the promise of affective science.
2003
The Neuropsychology of Anxiety
2003 Standout
Beware the dodo bird: The dangers of overgeneralization.
2002
Rumination Reconsidered: A Psychometric Analysis
2003 Standout
A Molecular Imaging Primer: Modalities, Imaging Agents, and Applications
2012
Dynamic mapping of human cortical development during childhood through early adulthood
2004 Standout
Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study
2007
Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants
2003 StandoutScience
Self-efficacy: Toward a unifying theory of behavioral change.
1977 Standout
Effect of Hypericum perforatum (St John's Wort) in Major Depressive Disorder
2002 Standout
Cognitive Therapy: Basics and Beyond
1995 Standout
The Role of Schema Processes in the Eating Disorders
2005
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Depressive Disorders
2007
Prevention of relapse in residual depression by cognitive therapy: a controlled trial.
1999
A Conceptual and Methodological Analysis of the Nonspecifics Argument.
2005
The neurobiology of depression: inroads to treatment and new drug discovery.
2005
Cerebral Metabolic Rates for Glucose in Mood Disorders
1985
Works of Michael E. Thase being referenced
Cognitive-Behavioral Analysis System of Psychotherapy as a Maintenance Treatment for Chronic Depression.
2004
Augmentation Strategies for Depression: History and Concepts
2007
Differential effects of treatments for chronic depression: A latent growth model reanalysis.
2010
The search for determinants of chronic depression: a review of six factors
2002
Which antidepressants have demonstrated superior efficacy? A review of the evidence
2007
Therapeutic Alliance in Depression Treatment: Controlling for Prior Change and Patient Characteristics.
2003
Treatment-Resistant Depression
2011
Dropouts versus completers among chronically depressed outpatients
2006
Research issues in the study of difficult-to-treat depression
2003
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma
2003
Effectiveness of St John's wort in major depression: a randomized controlled trial.
2001
Integration of Care: Integrating Psychotherapy and Pharmacotherapy to Improve Outcomes Among Patients With Mood Disorders
2003
Which symptoms predict recurrence of depression in women treated with maintenance interpersonal psychotherapy?
2008
Escitalopram in the treatment of major depressive disorder: A meta-analysis
2008
Antidepressant Combinations: Cutting Edge Psychopharmacology or Passing Fad?
2013
Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents
2007
Response and Remission Rates in Different Subpopulations With Major Depressive Disorder Administered Venlafaxine, Selective Serotonin Reuptake Inhibitors, or Placebo
2001
The clinical, psychosocial, and pharmacoeconomic ramifications of remission.
2001
Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination
2009
Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone.
2008
Patient Preference as a Moderator of Outcome for Chronic Forms of Major Depressive Disorder Treated With Nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, or Their Combination
2009
Sertraline versus imipramine to prevent relapse in chronic depression
2001
Gender differences in chronic major and double depression
2000
Does psychosocial functioning improve independent of depressive symptoms? a comparison of nefazodone, psychotherapy, and their combination
2002
Modafinil Augmentation of SSRI Therapy in Patients with Major Depressive Disorder and Excessive Sleepiness and Fatigue: A 12-Week, Open-label, Extension Study
2006
Double-blind Switch Study of Imipramine or Sertraline Treatment of Antidepressant-Resistant Chronic Depression
2002
Prevention of Recurrent Episodes of Depression With Venlafaxine ER in a 1-Year Maintenance Phase From the PREVENT Study
2007
Relative Antidepressant Efficacy of Venlafaxine and SSRIs: Sex-Age Interactions
2005
Chronic Depression
2005
An Overview of Vortioxetine
2014
Comparison of DSM-III-R chronic major depression and major depression superimposed on dysthymia (double depression): Validity of the distinction.
2000
The Effects of Psychotherapy, Nefazodone, and Their Combination on Subjective Assessment of Disturbed Sleep in Chronic Depression
2003
Duloxetine in the Prevention of Depressive Recurrences
2009
The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
2003 Standout
Therapeutic Alternatives for Difficult-to-Treat Depression: A Narrative Review of the State of the Evidence
2004
A Randomized, Double-Blind Comparison of Olanzapine/Fluoxetine Combination, Olanzapine, and Fluoxetine in Treatment-Resistant Major Depressive Disorder
2007
If at First You Donʼt Succeed
2010
Therapeutic Reactance as a Predictor of Outcome in the Treatment of Chronic Depression.
2003
Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors
2001
The Multifactorial Presentation of Depression in Acute Care
2013
Preventing Relapse and Recurrence of Depression:A Brief Review of Therapeutic Options
2006
The Treatment of Chronic Depression, Part 3
1998
Cardiovascular Profile of Duloxetine, a Dual Reuptake Inhibitor of Serotonin and Norepinephrine
2005
Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression
1993
Increased Amygdala and Decreased Dorsolateral Prefrontal BOLD Responses in Unipolar Depression: Related and Independent Features
2006
A Multicenter, Placebo-Controlled Study of Modafinil Augmentation in Partial Responders to Selective Serotonin Reuptake Inhibitors With Persistent Fatigue and Sleepiness
2005
Onset of depression and time to treatment entry: Roles of life stress.
1991
Challenges in preventing relapse in major depression
2002
Neural substrates of trait ruminations in depression.
2014
Comprehensive Analysis of Remission (COMPARE) with Venlafaxine versus SSRIs
2007
Research Design Features and Patient Characteristics Associated With the Outcome of Antidepressant Clinical Trials
2004
Efficacy and Tolerability of Once-Daily Venlafaxine Extended Release (XR) in Outpatients With Major Depression
1997
Biological markers, treatment outcome, and 1-year follow-up in endogenous depression: Electroencephalographic sleep studies and response to cognitive therapy.
1992
Fluoxetine versus placebo for the marijuana use of depressed alcoholics
1999
What Role Do Atypical Antipsychotic Drugs Have in Treatment-Resistant Depression?
2002
Predictors of Response to Acute Treatment of Chronic and Double Depression With Sertraline or Imipramine
1998
Comparing the Effects of Antidepressants: Consensus Guidelines for Evaluating Quantitative Reviews of Antidepressant Efficacy
2005
Self-Reported Depressive Symptom Measures: Sensitivity to Detecting Change in a Randomized, Controlled Trial of Chronically Depressed, Nonpsychotic Outpatients
2004
Can’t shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals
2002
A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients
2005
Relationships between Amygdala Volume and Activity during Emotional Information Processing Tasks in Depressed and Never‐Depressed Individuals
2003
Comparison of cognitive models of depression: Relationships between cognitive constructs and cognitive diathesis-stress match.
1997
Remission Prognosis for Cognitive Therapy for Recurrent Depression Using the Pupil: Utility and Neural Correlates
2011
Remission Rates Following Antidepressant Therapy With Bupropion or Selective Serotonin Reuptake Inhibitors
2005
The generation of life events in recurrent and non-recurrent depression
1999
Is psychotherapy an effective treatment for melancholia and other severe depressive states?
1999
Pupillary assessment and computational modeling of the Stroop task in depression
2004
Modafinil Augmentation of Selective Serotonin Reuptake Inhibitor Therapy in MDD Partial Responders with Persistent Fatigue and Sleepiness
2007
Randomized, Placebo-Controlled Trial of Fluoxetine for Acute Treatment of Minor Depressive Disorder
2004
MAOIs in the Contemporary Treatment of Depression
1995
Switching Strategies for the Treatment of Unipolar Major Depression
1997
Identifying an abnormal electroencephalographic sleep profile to characterize major depressive disorder
1997
Serotonin-1A receptor imaging in recurrent depression: replication and literature review
2007
Use of fMRI to Predict Recovery From Unipolar Depression With Cognitive Behavior Therapy
2006
Effects of Rumination and Initial Severity on Remission to Cognitive Therapy for Depression
2008
Interpersonal styles of chronically depressed outpatients: Profiles and therapeutic change.
2008
Selecting Methodologies for the Evaluation of Differences in Time to Response Between Antidepressants
2002
Efficacy of Mirtazapine for Prevention of Depressive Relapse
2001
A prospective test of criteria for response, remission, relapse, recovery, and recurrence in depressed patients treated with cognitive behavior therapy
1997
Citalopram Treatment of Fluoxetine-Intolerant Depressed Patients
2003
Effectiveness of antidepressants: comparative remission rates.
2003
Studying new antidepressants: if there were a light at the end of the tunnel, could we see it?
2002
The promise of cognitive behavior therapy for treatment of severe mental disorders: a review of recent developments
2014
Electroencephalographic Sleep in Psychotic Depression
1986
The relative efficacy of covert modeling procedures and guided participant modeling on the reduction of avoidance behavior
1976
Validation of a Hamilton subscale for endogenomorphic depression
1983
Patterns of attrition for psychosocial and pharmacologic treatments of depression.
1985
Recognition and diagnosis of atypical depression.
2007
Biological markers, treatment outcome, and 1-year follow-up in endogenous depression: Electroencephalographic sleep studies and response to cognitive therapy.
1992
The Use of the Sleep Laboratory in the Diagnosis of Affective Disorders
1983
Rumination: One Construct, Many Features in Healthy Individuals, Depressed Individuals, and Individuals with Lupus
2004
Management of treatment-resistant depression: psychotherapeutic perspectives.
2001
Comparing the Methods Used to Compare Antidepressants
2015
Comprehensive Analysis of Remission (COMPARE) with Venlafaxine versus SSRIs
2010
The role of homework in cognitive behavior therapy of depression.
2006
Cognitive behavior therapy of endogenous depression: Part 2: Preliminary findings in 16 unmedicated inpatients
1991
Treatment and Prevention of Depression
2002
Relapse and Recurrence of Depression
1995
Life events and the endogenous-nonendogenous distinction in the treatment and posttreatment course of depression
1985
Treatment of severe depression.
2000
Evaluating antidepressant therapies: remission as the optimal outcome.
2003
The Texas Medication Algorithm Project
1999
Clinical significance of reversed vegetative subtypes of recurrent major depression.
1991
The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies.
1998
Pharmacotherapy for ‘pure’ dysthymia: setraline vs. imipramine and placebo
1994
Recent developments in the pharmacotherapy of mood disorders.
1996
Frontiers of cognitive therapy
1997
Psychotherapy of refractory depressions
1997
Effects of social skill training, amitriptyline, and psychotherapy in unipolar depressed women
1984
Psychobiological correlates of poor response to cognitive behavior therapy: potential indications for antidepressant pharmacotherapy.
1993
Refractory Depression: Relevance of Psychosocial Factors and Therapies
1994
Treating antidepressant nonresponders with augmentation strategies: an overview.
1998
The Treatment of Chronic Depression, Part 1
1998
Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment
1992
Neurobehavioral Therapies in the 21st Century: Summary of an Emerging Field and an Extended Example of Cognitive Control Training for Depression
2007
Cognitive behavior therapy of endogenous depression: Part 1: An outpatient clinical replication series
1991
Redefining antidepressant efficacy toward long-term recovery.
1999
Psychotherapy of refractory depressions
1997
Natural History and Preventative Treatment of Recurrent Mood Disorders
1999
Shifts in affective balance during cognitive therapy of major depression.
1992
What is the investigator allegiance effect and what should we do about it?
1999
Treatment of imipramine-resistant recurrent depression, III: Efficacy of monoamine oxidase inhibitors.
1992
Do the Seconds Turn Into Hours? Relationships between Sustained Pupil Dilation in Response to Emotional Information and Self-Reported Rumination
2003